Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2022-06, Vol.57 (6), p.1025-1027
Hauptverfasser:	Borogovac, Azra, Keruakous, Amany, Bycko, Michelle, Holter Chakrabarty, Jennifer, Ibrahimi, Sami, Khawandanah, Mohamad, Selby, George B., Yuen, Carrie, Schmidt, Sarah, Autry, Marcus T., Al-Juhaishi, Taha, Wieduwilt, Matthew J., Asch, Adam S.
Format:	Artikel
Sprache:	eng
Schlagworte:	631/67/1059/2325 692/700/565/2319 Antigens Cell Biology Cell therapy Cell- and Tissue-Based Therapy Chimeric antigen receptors Correspondence Feasibility Studies Hematology Humans Immunotherapy, Adoptive - adverse effects Internal Medicine Lymphocytes T Medicine Medicine & Public Health Outpatients Public Health Receptors, Antigen, T-Cell - therapeutic use Receptors, Chimeric Antigen - therapeutic use Stem Cells Tertiary Care Centers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!